Previous findings from our group and others have demonstrated that COX-2 selective inhibitors, such as nimesulide (9, 11, 12), rofecoxib (13), SC58236 (14, 17), and NS398 (18) exert beneficial effects in ischemic stroke. This evidence concerns the gene PTGS2 and ischemic stroke.